SF Research Institute

02/18/2021

We are still recruiting Covid positive patients! If you or someone you know has tested positive in the past 72 hours fill out this screener to see if you qualify......

01/05/2021

The Regeneron treatment we are testing, REGN-COV2, is thoroughly discussed in this article in the New England Journal of Medicine.

"Our analysis suggests that an antibody cocktail against SARS-CoV-2 can also be an effective antiviral therapy, enhancing viral clearance and thus leading to improved outcomes..."

Original Article from The New England Journal of Medicine — REGN-COV2, a Neutralizing Antibody Cocktail, in Outpatients with Covid-19

12/29/2020

Tested positive for COVID-19 in past few days? You might be eligible for Regeneron’s paid clinical trial. Participants receive $3,650. Link here for eligibility screener: https://qfreeaccountssjc1.az1.qualtrics.com/jfe/form/SV_20lK1zEJrARMPiZ?fbclid=IwAR2EFIwfzsQOsXForv7L22SHTqTv8II6TEz-6DEN98yfHEUcnmRVx_jpCGc

deslizar para la versión en español. Si tiene COVID-19 ahora es posible que pueder hacer nuestro estudio pagado (por $3,650). Enlace aquí para determinar la elegibilidad: https://qfreeaccountssjc1.az1.qualtrics.com/jfe/form/SV_20lK1zEJrARMPiZ

12/27/2020

The SF Research Institute is currently recruiting patients for a paid clinical trial. We are testing Regeneron's REGN-COV2 treatment on people that are Covid-19 positive (with mild to moderate symptoms).

Patients receive a compensation of $3,650 if they participate.

If you recently tested positive for Covid-19 please check your eligibility: tny.sh/covidtrialsf

12/24/2020

Stay safe this holiday season from Covid-19 by avoiding large groups, wearing your mask, and spending time with loved ones outdoors!